Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/177298
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Masuet Aumatell, Cristina | - |
dc.contributor.author | Atouguia, Jorge | - |
dc.date.accessioned | 2021-05-14T09:02:17Z | - |
dc.date.available | 2021-05-14T09:02:17Z | - |
dc.date.issued | 2021-03-01 | - |
dc.identifier.uri | http://hdl.handle.net/2445/177298 | - |
dc.description.abstract | Typhoid fever is a bacterial infection caused by the Gram-negative bacterium Salmonella enterica subspecies enterica serovar Typhi (S. Typhi), prevalent in many low- and middle-income countries. In high-income territories, typhoid fever is predominantly travel-related, consequent to travel in typhoid-endemic regions; however, data show that the level of typhoid vaccination in travellers is low. Successful management of typhoid fever using antibiotics is becoming increasingly difficult due to drug resistance; emerging resistance has spread geographically due to factors such as increasing travel connectivity, affecting those in endemic regions and travellers alike. This review provides an overview of: the epidemiology and diagnosis of typhoid fever; the emergence of drug-resistant typhoid strains in the endemic setting; drug resistance observed in travellers; vaccines currently available to prevent typhoid fever; vaccine recommendations for people living in typhoid-endemic regions; strategies for the introduction of typhoid vaccines and stakeholders in vaccination programmes; and travel recommendations for a selection of destinations with a medium or high incidence of typhoid fever. | - |
dc.format.extent | 15 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Elsevier B. V. | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1016/j.tmaid.2020.101946 | - |
dc.relation.ispartof | Travel Medicine and Infectious Disease, 2021, vol. 40 | - |
dc.relation.uri | https://doi.org/10.1016/j.tmaid.2020.101946 | - |
dc.rights | cc by (c) Masuet Aumatell et al., 2021 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | - |
dc.subject.classification | Antibiòtics | - |
dc.subject.classification | Malalties bacterianes | - |
dc.subject.classification | Resistència als medicaments | - |
dc.subject.other | Antibiotics | - |
dc.subject.other | Bacterial diseases | - |
dc.subject.other | Drug resistance | - |
dc.title | Typhoid fever infection – Antibiotic resistance and vaccination strategies: A narrative review | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.date.updated | 2021-05-13T13:39:24Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 33301931 | - |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S1477893920304439-main.pdf | 3.5 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License